Skip to main content

alglucosidase alfa

Generic: alglucosidase alfa·Brand: Lumizyme

alglucosidase alfa: 2 clinical trials tracked.

alglucosidase alfa evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about alglucosidase alfa, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 1 study sponsors

Related indications

No linked indication is available.

Clinical Trial Registry Records (2)

A Phase 3 Double-blind Randomized Study to Assess the Efficacy and Safety of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease Compared With Alglucosidase Alfa/Placebo

NCT03729362Registry updated 2025-09-11·Phase 3·FOLD
Completed

Primary endpoint: Change From Baseline to Week 52 in 6 Minute Walk Distance (6MWD)

InterventionalRandomizeddouble125 enrolledStarted 2018-12Completion 2021-0150 sites · Argentina, Australia, Austria, Belgium…Amicus Therapeutics

An Open-label Ascending Dose Cohort Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of Avalglucosidase Alfa (NeoGAA, GZ402666) in Patients With Infantile-onset Pompe Disease Treated With Alglucosidase Alfa Who Demonstrate Clinical Decline or Sub-optimal Clinical Response

NCT03019406Registry updated 2026-01-30·Phase 2
Active, not recruiting

Primary endpoint: PAP: Number of Participants With Treatment-emergent Adverse Events (TEAEs), Serious Treatment-emergent Adverse Events, and Adverse Event of Special Interest (AESI)

InterventionalRandomizedopen22 targetStarted 2017-10Completion 2027-0812 sites · France, Japan, Taiwan, United Kingdom…Genzyme, a Sanofi Company